Co-Encapsulation of Multiple Antineoplastic Agents in Liposomes by Exploring Microfluidics
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083820 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sajid Asghar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nanotechnology Laboratory, TRANSCEND Department, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot, 700483 Iași, Romania. Hauptthemen laut MEDLINE: Liposomes, Microfluidics, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, H2020 grant—ERA-Chair.
Abstract (Originalsprache)
The inherent complexity of cancer proliferation and malignancy cannot be addressed by the conventional approach of relying on high doses of a single powerful anticancer agent, which is associated with poor efficacy, higher toxicity, and the development of drug resistance. Multiple drug therapy (MDT) rationally designed to target tumor heterogeneity, block alternative survival pathways, modulate the tumor microenvironment, and reduce toxicities would be a viable solution against cancer. Liposomes are the most suitable carrier for anticancer MDT due to their ability to encapsulate both hydrophilic and hydrophobic agents, biocompatibility, and controlled release properties; however, an adequate manufacturing method is important for effective co-encapsulation. Microfluidics involves the manipulation of fluids at the microscale for the controlled synthesis of liposomes with desirable properties. This work critically reviews the use of microfluidics for the synthesis of anticancer MDT liposomes. MDT success not only relies on the identification of synergistic dose combinations of the anticancer modalities but also warrants the loading of multiple therapeutic entities within liposomes in optimal ratios, the protection of the drugs by the nanocarrier during systemic circulation, and the synchronous release at the target site in the same pattern as confirmed in preliminary efficacy studies. Prospects have been identified for the bench-to-bedside translation of anticancer MDT liposomes using microfluidics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanotechnology Laboratory, TRANSCEND Department, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot, 700483 Iași, Romania.
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad 38000, Pakistan.
- Proteomics Laboratory, TRANSCEND Research Center, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot Street, 700483 Iași, Romania.
- Department of Pharmacology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.
- Department of NanoSciences, MEDFUTURE-Institute for Biomedical Research, "Iuliu Hatieganu" University of Medicine and Pharmacy, 4-6 Pasteur Street, 400349 Cluj-Napoca, Romania.
- Faculty of Chemistry, Alexandru Ioan Cuza University of Iași, 11 Bd. Carol I, 700506 Iași, Romania.
ORCID-Profile: Sajid Asghar, Rares-Ionut Stiufiuc
Förderung
- European Commission
- H2020 grant—ERA-Chair
Zitieren
APA
Asghar, S., Iliescu, R., Stiufiuc, R. I., & Dragoi, B. (2025). Co-Encapsulation of Multiple Antineoplastic Agents in Liposomes by Exploring Microfluidics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083820
Vancouver
Asghar S, Iliescu R, Stiufiuc RI, Dragoi B. Co-Encapsulation of Multiple Antineoplastic Agents in Liposomes by Exploring Microfluidics. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083820
BibTeX
@article{Asghar2025,
author = {Asghar, Sajid and Iliescu, Radu and Stiufiuc, Rares-Ionut and Dragoi, Brindusa},
title = {Co-Encapsulation of Multiple Antineoplastic Agents in Liposomes by Exploring Microfluidics},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083820}
}
EUVIMED